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DOI 10.1016/j.stem.2008.11.014Conventional mouse and human embry-
onic stem cells (ESCs) can be typically
derived by in vitro culture of blastocysts
(Martin, 1981; Thomson et al., 1998), and
induced pluripotent stem cells (iPSCs)
can be generated by reprogramming
somatic cells using defined genetic trans-
duction methods (Takahashi et al., 2007;
Takahashi and Yamanaka, 2006; Yu
et al., 2007). In both cases, different
signaling pathways appear to regulate plu-
ripotency with different characteristics in
the two species. However, while rat ESC-
like cells have been established based on
certain traits (Demers et al., 2007; Ruhnke
et al., 2003; Schulze et al., 2006; Ueda
et al., 2008), to date, these lines fall short
of exhibiting true pluripotency (e.g., fail to
form teratoma or no/little contribution to
chimerism) and thus cannot be considered
authentic rat ESCs. Here, we reveal
combined genetic reprogramming and
chemical conditions that generate and
maintain rat iPSCs (riPSCs) that can give
rise to teratomas and contribute exten-
sively to chimeric rats. The same strategy
is also sufficient to generate atypical
human iPSCs (hiPSCs) that exhibit similar
colony morphology and self-renewal
requirements/signaling responses as those
of mESCs.
Pluripotent stem cells have also been
derived from the postimplantation egg
cylinder stage epiblasts of mouse and
rat (Brons et al., 2007; Tesar et al.,
2007). These populations have been
termed epiblast stem cells (EpiSCs).
EpiSCs seem to correspond very closely
to conventional hESCs with respect to
colony morphology and the culture/
signaling requirements that maintain plu-
ripotency but exhibit a range of significant
phenotypic and signaling response differ-
ences from conventional mESCs. For16 Cell Stem Cell 4, January 9, 2009 ª2009example, LIF is insufficient to support
either hESCs or EpiSCs, and BMP4,
which is also required in conjunction
with LIF by mESCs for self-renewal,
induces hESC/EpiSCs to differentiate into
trophoblasts or primitive endoderm. In
addition, bFGF and Activin A are dispens-
able for mESC self-renewal and induce
mESC differentiation, but required by
EpiSCs and hESCs. Finally, both rat and
mouse EpiSCs show little or no ability to
be incorporated into preimplantation
embryos and subsequently contribute to
chimeras (Brons et al., 2007; Tesar et al.,
2007).
Collectively, we hypothesized that, by
altering the growth conditions used to
select and maintain pluripotent rat cells,
lines that exhibit mESC traits and
contribute to chimeric animals might be
isolated. Given that similar cocktails of
transcription factors have been success-
ful in reprogramming somatic murine
and human cells to pluripotency, we em-
ployed this strategy to generate rat iPSCs.
Rat liver progenitor cells (diploid cell line,
WB-F344 [Grisham et al., 1993]) were
transduced with Oct4, Sox2, and Klf4
using retroviral vectors and then split
onto MEF feeder cells and cultured
in conventional mESC medium containing
knockout serum replacement and LIF (see
Supplemental Data for detailed Experi-
mental Procedures). Compact, alkaline
phosphatase (ALP)-positive colonies that
exhibit morphological similarity to mESCs
were observed 10 days after transduction
with an efficiency of 0.4% (Figure 1A).
When the ESC-like colonies were isolated
and subcultured in the same medium,
however, they quickly differentiated
and lost ESC morphology (Figure 1B),
suggesting that conventional mESC
medium conditions are not sufficient toElsevier Inc.maintain the putative riPSCs in a pluripo-
tent state.
Given the notion that small molecules
can inhibit key differentiation-inducing
pathways, we and others have previously
identified and used small molecules to
support mESC self-renewal in a more
robust manner (Chen et al., 2006; Schu-
gar et al., 2008; Xu et al., 2008). We
used this chemical strategy, combined
with the knowledge of signaling differ-
ences required for maintenance of self-
renewal of mESC versus EpiSC/hESC, to
design candidate cocktails to select and
maintain pluripotent riPSCs in culture.
mESCs require BMP4, in part to inhibit
ERK activation, whereas hESCs/EpiSCs
exhibit high levels of ERK activation in
response to FGF signaling. In addition,
GSK3 inhibition by specific small mole-
cules to elevate Wnt signaling seems to
contribute favorably to self-renewal of
both mESCs and hESCs when combined
with appropriate modulation of other
pathways (Ludwig et al., 2006; Umehara
et al., 2007) Therefore, we supplemented
the standard mESC conditions with
a combination of a MEK inhibitor (0.5 mM
PD0325901) and a GSK3b inhibitor
(3 mM CHIR99021) and observed that
riPSCs can be maintained short-term in
the presence of these chemicals but still
exhibit extensive spontaneous differentia-
tion (Figure 1C). Indeed, after serial
passages, the growth of putative riPSCs
treated with only PD0325901 and
CHIR99021 declined, and the culture
deteriorated due to the expansion of
differentiated cells. Recent studies
demonstrated that addition of the FGFR
inhibitor PD173074 to the above cocktail
is sufficient to maintain mESC pluripo-
tency in the absence of LIF (Ying et al.,
2008). However, our MEK and GSK3b
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WB-F344 rat liver epithelial cells were transduced with Oct4, Sox2, and Klf4 by retroviruses and then trans-
ferred to MEF feeder cells in conventional mESC medium with LIF. Colonies with mESC morphology were
observed 10 days after transduction (A) but could not be maintained in conventional mESC culture
conditions (B). In the presence of 0.5 mM PD0325901 and 3 mM CHIR99021, riPSCs can only be short-
term maintained in culture with extensive spontaneous differentiation as indicated (C). With the combina-
tion of 0.5 mM PD0325901, 3 mM CHIR99021, and 0.5 mM A-83-01, riPSCs can long-term and homoge-
nously self-renew (D) and form mESC-like domed colonies in culture (E). The expression of Oct4 (F),
Sox2 (G), SSEA-1([H], green), and Nanog ([H], red) by riPSCs were detected by immunocytochemistry.
The expression of endogenous typical pluripotency markers and the silencing of transduced genes
were analyzed by RT-PCR (I). Four clonal riPSCs were subjected to RT-PCR analysis. WB-F344 cells
and R1 mESCs were used as controls. The methylation status of the Oct4 promoter in riPSCs and WB-
F344 cells was analyzed by bisulfite sequencing (J). Open circles indicate unmethylated, and filled circles
indicate methylated CpG dinucleotides. A chromosome spread of riPSCs is depicted (K). Hematoxylin and
eosin staining of teratoma sections of riPSCs (clonal 1 line) is provided in (L)–(N). Two chimeric rats are
displayed in (O) and (P) after injection of riPSCs (clonal 1) into Brown-Norway rat blastocysts. Scale
bars, 50 mm.inhibitor-treated riPSC cultures were not
improved with the addition of 0.1 mM
PD173074 (data not shown). Because the
TGFb/Activin A/Nodal signaling cascade
is essential to maintain undifferentiated
hESCs and EpiSCs, but dispensable for
mESC self-renewal, we tested whether
the addition of an inhibitor of the type
1 TGFb receptor, ALK5 (A-83-01) could
help stabilize our riPSC cultures. Remark-
ably, with the combination of 0.5 mM
PD0325901, 3mM CHIR99021, and 0.5mM
A-83-01, riPSCs grow as a relativelyhomogeneous population, and the spon-
taneous differentiation observed in the
absence of A-83-01 was substantially
inhibited (Figure 1D). Under such condi-
tions, the clonal expansion efficiency was
also significantly increased in comparison
to the combination of PD0325901 and
CHIR99021 (Figure S1 available online).
Furthermore, although LIF alone was not
sufficient to sustain riPSC self-renewal,
only very small ALP-positive colonies
were detectable in the absence of LIF,
and these colonies were not maintainedCell Stem Ceover long-term culture (Figure S1). In
contrast, riPSCs cultured in the presence
of the combined cocktail of LIF,
PD0325901, A-83-01, and CHIR99021
have been maintained to date for more
than 30 passages without obvious differ-
entiation or decreased proliferation. The
colonies that result resemble the typical
domed colonies formed by conventional
mESCs (Figure 1E). Notably, riPSC
cultures require the continued presence
of the ERK, GSK3b, and ALK5 inhibitors,
in that the colonies lose ESC morphology
and differentiate within one passage if the
chemicals are removed from the medium.
In addition to exhibiting morphologic
similarity to mESC cultures, immunocyto-
chemistry revealed that riPSCs express
typical mESC markers, such as Oct4 (Fig-
ure 1F), Sox2 (Figure 1G), SSEA-1 (Fig-
ure 1H, green), and Nanog (Figure 1H,
red) but are negative for the hESC
markers SSEA3, SSEA4, and TRA-1-81
(data not shown). RT-PCR analysis of
four clonal riPSC lines using rat gene
primers confirmed the expression of the
endogenous rat Oct4, Sox2, Nanog, Klf4,
Rex-1, TDGF2, FGF4, and Eras genes
(Figure 1I). By using transgene-specific
primers, RT-PCR analysis revealed that
the transduced mouse Oct4, Sox2, and
Klf4 genes were largely silenced (Fig-
ure 1I). Analysis of the methylation status
of the rat Oct4 promoter showed differen-
tial methylation between riPSCs and
parental WB-F344 cells, in that the locus
is almost completely demethylated in the
reprogrammed cells (Figure 1J). In addi-
tion, karyotyping analysis revealed a
normal chromosome number (i.e., 42) in
riPSCs (Figure 1K). Thus, collectively,
riPSCs share multiple common molecular
features with mESCs. Notably, among
these shared traits are the expression of
Rex-1 and ALP, which are markers of
ESCs and early epiblasts that are absent
in post-implantation stage epiblasts and
EpiSCs.
To extend the phenotypic analysis of
riPSCs and their comparison to mESCs,
the developmental potential of riPSCs
was examined in in vitro differentiation
assays. Immunostaining after a standard
embryoid body differentiation protocol
showed that riPSCs could differentiate
into endoderm (Albumin and Pdx1)
(Figures S2A and S2B), neuroectoderm
(bIII-tubulin, Tuj1) (Figure S2C), and
mesoderm (brachyury) (Figure S2D)ll 4, January 9, 2009 ª2009 Elsevier Inc. 17
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IMR90 human fibroblasts were transduced with Oct4, Sox2, Nanog, and Lin28 by lentiviruses. The hiPSC
colonies were observed 3 weeks after transduction (A), picked up at the fourth week after transduction,
and were stably maintained under the cocktail of hLIF, 0.5 mM PD0325901, 0.25 mM A-83-01, and 3 mM
CHIR99021. Such hiPSCs formed domed colonies similar in appearance to mESCs (B). Under such condi-
tions, the expression of pluripotency markers by hiPSCs was analyzed by ALP staining (C), immunostain-
ing (D–I), and RT-PCR (J). Four clonal hiPSC lines were subjected to RT-PCR analysis, and parental IMR90
cells were used as controls. The methylation status of the Oct4 promoter in hiPSCs, IMR90 cells, and H1
hESCs was analyzed using bisulfite sequencing (K). Open circles indicate unmethylated, and filled circles
indicate methylated CpG dinucleotides. (L) A karyotype analysis of hiPSCs is provided. Hematoxylin and
eosin staining of teratoma sections of hiPSCs appears in (M) and (N). Scale bars, 50 mm.derivatives. Next, the in vivo develop-
mental potential of riPSCs was assessed.
After transplantation into Severe Com-
bined Immunodeficient (SCID) mice,
riPSCs formed teratomas, which con-
sisted of all three germ layers, including
neuroepithelium structures (ectoderm,
Figure 1L), ciliated epithelium of airway
(endoderm, Figure 1M, arrow), and carti-
lage structures (mesoderm, Figure 1N).
Most remarkably, after injection into
Brown-Norway rat (black fur) blastocysts
(n = 18), three rats were born and
all exhibited extensive coat-color chime-
rism (Figures 1O and 1P). However, no
germline transmission has been detected
yet.
Taken together, the above results indi-
cate that the addition of the combined
inhibitor cocktail to standard mESC
growth conditions is sufficient to support
and maintain the pluripotency of riPSCs
with traits that resemble mESCs and
with distinct morphological, signaling,
and functional properties from EpiSCs
and hESCs. Consistent with this pattern,
standard bFGF-containing culture condi-
tions that support conventional hESCs/18 Cell Stem Cell 4, January 9, 2009 ª2009EpiSCs and hiPSCs are not sufficient to
yield our described riPSCs but do give
rise to colonies that resemble EpiSCs
(data not shown). To assess whether
distinct hiPSCs that share colony
morphology and key signaling responses
with conventional mESCs could be gener-
ated using the riPSC-supporting chemical
inhibitor cocktail, we transduced IMR90
human fibroblasts with Oct4, Sox2,
Nanog, and Lin28 in mESC medium con-
taining hLIF. Remarkably, we found that
primary hiPSC colonies could be effec-
tively generated with a similar kinetics
and efficiency (Figure 2A, 1520 iPSC
colonies from 1 3 105 transduced cells
on average) as has been reported using
conventional hESC conditions (Yu et al.,
2007), and these colonies could be
subsequently selected/stabilized and
further expanded with the addition of the
chemical cocktail of ALK5, GSK3, and
MEK inhibitors. The resulting hiPSCs
appear to be homogenous and self-renew
over long-term periods (>20 passages) in
the presence of hLIF and the chemical
cocktail of PD0325901, A-83-01, and
CHIR99021 (Figure 2B). In contrast toElsevier Inc.conventional hESCs and previously iso-
lated hiPSCs, the chemically selected
hiPSCs form more compact, ALP-positive
domed colonies similar in appearance to
mESCs (Figure 2C). In addition, these
colonies were clearly resistant to differen-
tiation in response to the MEK and ALK5
inhibitors, whereas the conventional
hESC line H1 differentiated rapidly under
the same conditions (data not shown).
hiPSCs isolated under the riPSC-defined
conditions homogenously express typical
pluripotency markers, such as Oct4,
Sox2, Nanog, SSEA3, SSEA-4, and TRA-
1-81 (Figures 2D–2I), and RT-PCR anal-
ysis of four clonal hiPSC lines confirmed
the expression of the endogenous human
Oct4, Sox2, Nanog, Rex-1, TDGF2, and
FGF4 (Figure 2J). By using transgene-
specific primers, RT-PCR analysis re-
vealed that the transduced Oct4, Sox2,
and nanog genes were largely silenced
(Figure 2J). Moreover, these hiPSCs
showed similar DNA methylation patterns
at the Oct4 promoter, as observed in H1
human ESCs and distinct from parental
IMR90 fibroblasts (Figure 2K). Karyotyp-
ing analysis revealed the normal 46, XX
chromosomes (Figure 2L). Similar to
riPSCs, the inhibitor cocktail was required
to maintain the domed colony morphology
and long-term in vitro self-renewal of the
hiPSCs, in that removal of the inhibitor
cocktail led to the loss of colony morphol-
ogy within a single passage. In contrast,
removing hLiF from the medium did not
show immediate/dramatic effects on the
cells. However, hLiF seems to be useful
for the long-term culture of hiPSCs; when
maintained in medium containing the
chemical inhibitors but without hLiF,
hiPSC cultures deteriorate gradually and
have not been homogenously maintained
beyond ten passages. Nevertheless, the
exact signaling mechanism responsible
for self-renewal of the chemically selected
hiPSCs remains to be determined.
Importantly, immunocytochemical anal-
yses confirmed that hiPSCs generated
under riPSC conditions have the capacity
to differentiate into endoderm (Albumin,
Figure S3A), neuroectoderm (bIII-tubulin,
Tuj1, Figure S3B), and mesoderm (bra-
chyury, Figure S3C) derivatives in vitro.
Furthermore, after transplantation into
SCID mice, hiPSCs formed teratomas,
which consisted of all three germ layers,
including neuroepithelium-like structure
(ectoderm, Figure 2M), epithelial tube
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cartilage-like structure (mesoderm, Fig-
ure 2N). Taken together, the above results
suggest that atypical human pluripotent
stem cells that exhibit the characteristic
morphology and key signaling responses
of conventional mESCs can be generated
and maintained long-term if the appro-
priate growth conditions are provided.
Although embryonic stem cells have
been derived from mice since 1981
(Martin, 1981), attempts to derive their
counterparts from other rodents, such as
rat, have not, to date, completely suc-
ceeded (Demers et al., 2007; Ruhnke
et al., 2003; Schulze et al., 2006; Ueda
et al., 2008). By combining genetic repro-
gramming with the addition of chemical
inhibitors, we were able to generate
rat and human pluripotent stem cells
that exhibit some characteristics of
conventional mESCs, such as colony
morphology and culture requirements/
signaling responses. Under this specific
cocktail of small molecules, riPSCs grow
stably in culture. In addition, riPSCs are
capable of contributing extensively to
chimerism in vivo, and thus they demon-
strate a degree of pluripotency that had
yet to be shown for cultured cells from
this species. Rats are better suited for
physiological and behavioral studies than
mice and have the potential to provide
excellent models for multigenic human
diseases. However, realizing the experi-
mental potential of this species has been
hindered by the unavailability of rat stem
cells that are pluripotent in vivo. Our
establishment of pluripotent rat cells and
the strategy to identify appropriate chem-
ical cocktails that maintain them will pave
the way to generate gene-targeted rats for
biomedical research. In addition, hiPSCsgrown in these conditions appear to be
more robust and exhibit traits that suggest
that they occupy a pluripotent state that is
similar to that defined by conventional
mESCs and distinct from conventional
hESCs. These findings also underscore
the combined importance of the TGF-b,
WNT, and FGF pathways in regulating plu-
ripotency in different species.
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